Pharma.Aero is continuing to welcome new members with Japanese airport operator Kansai Airports signing up to the organisation.
Kansai Airports gained the operating rights of Kansai International Airport and Osaka International Airport from New Kansai International Airport Company on 1 April 2016 and has been working on upgrading infrastructure for pharmaceuticals.
In August 2017 the company formed the KIX Pharma Community to undergo International Air Transport Association (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) with six companies, Bollore Logistics Japan; CKTS; Hankyu Hanshin Express; JAL Kansai Aircargo System; Mitsubishi Logistics and Yusen Logistics participating.
Pharma.Aero vice chairman and representative of Miami International Airport, Jimmy Nares says: “The addition of KIX as a member of Pharma.Aero along with Southeast Asian airports who are already members (Singapore, Changi International Airport and Hong Kong International Airport), bolsters MIA’s initiative to increase cargo and add passenger service with airports in that region.”
Shingu Hayato of Kansai Airport’s cargo development group aviation sales & marketing department says: “Although Japan is a country with large distribution of pharmaceuticals, quality standards and distribution are not advanced. It is necessary to introduce world standards and raise transportation quality in Japan.
“By joining Pharma.Aero, we are working closely with not only our stakeholders, but also other airports and shippers in other areas to improve transportation quality.”
Penta Freight embarking on IATA CEIV Pharma certification and president, Aditya Parulkar says it is “honoured” to be part of Pharma.Aero.
Parulkar says: “In its 25th year in business, Penta Freight sees Pharma.Aero as an ideal platform to collaborate with like minded communities across the world and invigorate their global footprint.”
Unisys global director of life sciences, Camille Diges says its company’s track record of bringing solutions to the life sciences, healthcare and air cargo industries brings a unique perspective to the Pharma.Aero community.
Diges says: “Like other members of the Pharma.Aero organisation, we share a commitment to identifying best practices to improve visibility and security within every stage of the supply chain. By working together, we can effect change that will lead to better patient health.”
